Risk of Atherosclerosis Due to HMGB1-dependent Platelet-derived Microparticles in Patients with Type 2 Diabetes Mellitus
We measured high mobility group box 1 protein (HMGB1) and platelet-derived microparticles (PDMP) in blood samples from patients with untreated type 2 diabetes mellitus (T2DM). We examined the effects of a combination of sodium/glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DP...
Saved in:
| Main Authors: | Shosaku Nomura MD, Takehito Taniura MD, Jun Ichikawa MD, Ayako Iwama MD, Tomoki Ito MD |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-11-01
|
| Series: | Clinical and Applied Thrombosis/Hemostasis |
| Online Access: | https://doi.org/10.1177/10760296241302082 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expression of Procoagulant Microparticles Assessed by Thrombin Generation Test in Cirrhosis
by: Mejda Belakremi MD, et al.
Published: (2025-07-01) -
HMGB1 as a biomarker for myeloproliferative neoplasm complicated with atherosclerosis
by: Lunbi Wu, et al.
Published: (2025-05-01) -
Immature Platelets and Platelet Reactivity in Patients with COVID-19
by: Yulia Balmakov BMSc, et al.
Published: (2025-02-01) -
Platelet-Derived Growth Factor has Context-Dependent Effects on Osteogenesis in Bone Marrow-Derived Cells
by: Nicholas Huffman, et al.
Published: (2024-12-01) -
Advanced Subclinical Atherosclerosis and Low-Dose Aspirin
by: Michael J. Blaha, MD, MPH, et al.
Published: (2025-07-01)